Protagenic Therapeutics, Inc. (14) | Note Agreements (3)
- 5.00% Promissory Note (Filed With SEC on May 17, 2021)
- Form of Convertible Note Purchase Agreement (Filed With SEC on November 21, 2019)
- Form of Convertible Promissory Note (Filed With SEC on November 21, 2019)